Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.

Salama A.

Transfus Med Hemother. 2015 Sep;42(5):294-301. doi: 10.1159/000438731. Epub 2015 Aug 10. Review.

2.

Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?

Worch J, Makarova O, Burkhardt B.

Cancers (Basel). 2015 Jan 29;7(1):305-28. doi: 10.3390/cancers7010305. Review.

3.

Treatment of autoimmune hemolytic anemias.

Zanella A, Barcellini W.

Haematologica. 2014 Oct;99(10):1547-54. doi: 10.3324/haematol.2014.114561. Review.

4.

Rituximab in the treatment of autoimmune haemolytic anaemia.

Rodrigo C, Rajapakse S, Gooneratne L.

Br J Clin Pharmacol. 2015 May;79(5):709-19. doi: 10.1111/bcp.12498. Review.

5.

A fetal hemolytic anemia in a child with cytomegalovirus infection.

Hosseeini S, Ansari Sh, Kalantar E, Sabzechian M, Alibeik A, Dorgalaleh A.

Iran J Ped Hematol Oncol. 2014;4(2):78-83. Epub 2014 Apr 20.

6.

Rituximab therapy for refractory autoimmune thrombocytopenia in patients with systemic lupus erythematosus.

Atay D, Oztürk G, Anak S, Devecioğlu O, Unüvar A, Karakaş Z, Ağaoğlu L.

Turk J Haematol. 2012 Mar;29(1):92-3. doi: 10.5505/tjh.2012.26539. Epub 2012 Mar 5. No abstract available.

7.

Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Smith JR, Rosenbaum JT.

JAMA Ophthalmol. 2014 May;132(5):572-8.

8.

Rituximab used in three cases with relapsed non-Hodgkin's lymphoma.

Elli M, Yilmaz S, Aydin R, Murat S, Bilgici MC, Dagdemir A.

Mol Clin Oncol. 2013 May;1(3):550-552. Epub 2013 Mar 5.

9.

Autoimmune Hemolytic Anemia due to Varicella Infection.

Kumar KJ, Kumar HC, Manjunath VG, Arun V.

Iran J Pediatr. 2013 Aug;23(4):491-2. No abstract available.

10.

Anti B cell targeted therapy for autoimmune hemolytic anemia in an infant.

Makadia D, Siddaiahgari SR, Latha MS.

Indian J Pharmacol. 2013 Sep-Oct;45(5):526-7. doi: 10.4103/0253-7613.117755.

11.

Immunotherapy treatments of warm autoimmune hemolytic anemia.

Liu B, Gu W.

Clin Dev Immunol. 2013;2013:561852. doi: 10.1155/2013/561852. Epub 2013 Sep 11. Review.

12.

An Attempt to Induce Transient Immunosuppression Pre-erythrocytapheresis in a Girl With Sickle Cell Disease, a History of Severe Delayed Hemolytic Transfusion Reactions and Need for Hip Prosthesis.

Cattoni A, Cazzaniga G, Perseghin P, Zatti G, Gaddi D, Cossio A, Biondi A, Corti P, Masera N.

Hematol Rep. 2013 Jun 28;5(2):36-8. doi: 10.4081/hr.2013.e11. Print 2013 Jun 28.

13.

Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome.

Farruggia P, Macaluso A, Tropia S, Genova S, Paolicchi O, Di Marco F, D'Angelo P.

Pediatr Rep. 2011 Jun 16;3(2):e15. doi: 10.4081/pr.2011.e15.

14.

Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.

Granel B, Rossi P, Bernard F, Dettori I, Costello R, Demoux AL, Bagneres D, Lafforgue P, Frances Y.

BMJ Case Rep. 2009;2009. pii: bcr09.2008.0857. doi: 10.1136/bcr.09.2008.0857. Epub 2009 Mar 6.

15.

Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: a case report.

Beretta C, Leoni V, Rossi MR, Jankovic M, Patroniti N, Foti G, Biagi E.

J Med Case Rep. 2009 Apr 1;3:6443. doi: 10.1186/1752-1947-3-6443.

16.

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T.

Pediatr Blood Cancer. 2009 Jul;52(7):847-52. doi: 10.1002/pbc.21965.

17.

Treatment with rituximab in benign and malignant hematologic disorders in children.

Giulino LB, Bussel JB, Neufeld EJ; Pediatric and Platelet Immunology Committees of the TMH Clinical Trial Network.

J Pediatr. 2007 Apr;150(4):338-44, 344.e1. Review. No abstract available.

18.

Case report of an acquired factor XIII inhibitor: diagnosis and management.

Gregory TF, Cooper B.

Proc (Bayl Univ Med Cent). 2006 Jul;19(3):221-3.

19.

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.

Yomtovian R, Niklinski W, Silver B, Sarode R, Tsai HM.

Br J Haematol. 2004 Mar;124(6):787-95. Review.

Items per page

Supplemental Content

Write to the Help Desk